Neonatal Thyroid Stimulating Hormone and Subsequent Diagnosis of Autism Spectrum Disorders and Intellectual Disability.
Newborn TSH levels do not predict later autism or intellectual disability, so they should not guide early intervention decisions.
01Research in Context
What this study did
Bellon-Harn et al. (2020) asked whether the heel-prick TSH test done on every newborn forecasts later autism or intellectual disability. They tracked thousands of babies until doctors gave or ruled out those diagnoses.
The team compared TSH quartiles. They also split autism into ‘with regression’ and ‘without regression’ to look for subtler links.
What they found
Across the whole cohort, high or low TSH did not raise autism or ID risk. Only one small slice—kids who later showed autism with regression and were in the top TSH quartile—showed a weak inverse trend.
The authors conclude that routine newborn TSH is not a useful early screener for either condition.
How this fits with other research
Zhong et al. (2024) extends this picture by moving earlier in time. They found that high free thyroxine in mid-pregnancy, not newborn TSH, links to more autistic traits at preschool age. Together the papers show timing matters: gestational thyroid excess may nudge development, yet the birth-level TSH snapshot adds no new signal.
Jeon et al. (2026) used the same large-cohort, quasi-experimental style but swapped the exposure. They showed that early intubation, unlike TSH, strongly predicts later autism. The contrast underlines that not all neonatal flags are equal; some medical events carry far more weight than hormone levels.
Pham et al. (2022) looked at a broad environmental risk index and found positive links to autism symptoms at age two. Their positive findings and L’s null result illustrate a common pattern: social and environmental risks often show clearer signals than single biological markers.
Why it matters
You can stop wondering about mildly high or low newborn TSH reports when you meet a new client. The test still matters for congenital hypothyroidism, but it will not tell you who needs extra autism surveillance. Focus your early-detection energy on proven red flags: intubation history, environmental risk bundles, or clear developmental delays. Save screening time for skills-based tools and parent questionnaires that actually predict later diagnosis.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Remove TSH values from your early-risk checklist and replace that space with proven items like intubation history or parent concern about lost words.
02At a glance
03Original abstract
Hypothyroid conditions in early life, if left untreated, are associated with adverse neurodevelopmental outcomes, including intellectual disability (ID). However, evidence addressing the role of neonatal thyroid hormone insufficiencies in the altered neurobiology underlying autism spectrum disorders (ASD), particularly among its subphenotypes, is limited. We conducted a population-based, case-control study among a sample of children born during 2000-2003 in Southern California. We examined neonatal thyroid-stimulating hormone (TSH) measured during routine newborn screening among children later diagnosed with ASD (n = 518) or ID (n = 145) and general population (GP) controls (n = 399). TSH was further analyzed in relation to ASD subgroups of intellectual ability and onset type (early-onset ASD vs. ASD with regression) ascertained by expert review of developmental services records. Odds ratios (ORs) of the differences in TSH between groups were obtained from multivariate logistic regression. We examined neonatal TSH as continuous (ln-transformed) and as quartiles. We found no association between continuous neonatal TSH levels and ASD (adj-OR: 1.00, 95% CI: 0.79-1.26) nor ID (adj-OR = 1.01, 95% CI: 0.73-1.40). Among ASD subphenotypes, we observed a suggestive inverse trend between ASD with regression and TSH, though the association only reached statistical significance in the highest TSH quartile (adj-OR: 0.50, 95% CI: 0.26-0.98). While there was little evidence that neonatal TSH is related to overall ASD risk, more work is needed to understand the influence of thyroid hormones on ASD subphenotypes. Autism Res 2020, 13: 444-455. © 2019 International Society for Autism Research,Wiley Periodicals, Inc. LAY SUMMARY: Low levels of thyroid hormone at birth can negatively impact brain development. We studied whether newborn levels of thyroid stimulating hormone (TSH) were associated with autism spectrum disorder (ASD) and its subtypes in a sample of children born in California. Newborn TSH was not related to the overall risk of ASD or intellectual disability. However, the relationships of thyroid hormone levels at birth and specific subtypes of ASD, particularly ASD with developmental regression, may need more research.
Autism research : official journal of the International Society for Autism Research, 2020 · doi:10.1002/aur.2247